Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Selective iNOS inhibitors show potential in the treatment of endotoxin-induced uveitis

Aug. 21, 2003

Phase IIIb results support use of diquafosol in dry eye

Aug. 20, 2003

AlphaCor introduction for cornea transplant patients who reject human tissue

Aug. 20, 2003

Santen seeks Japanese manufacturing approval for vernal keratoconjunctivitis treatment

Aug. 18, 2003

ISTA files second Vitrase NDA

Aug. 7, 2003

Squalamine improves visual outcomes in phase I/II wet AMD study

Aug. 6, 2003

Priority review for diquafosol tetrasodium NDA

Aug. 5, 2003

IGF-I peptides useful in ophthalmology and dermatology

Aug. 4, 2003

IOP-lowering agents prepared and tested by Alcon researchers

July 28, 2003

CG-5601, a potential alternative to thalidomide for ocular inflammation

July 11, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...